Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients

Bicanic, Tihana, Muzoora, Conrad, Brouwer, Annemarie E., Meintjes, Graeme, Longley, Nicky, Taseera, Kabanda, Rebe, Kevin, Loyse, Angela, Jarvis, Joseph, Bekker, Linda‐Gail, Wood, Robin, Limmathurotsakul, Direk, Chierakul, Wirongrong, Stepniewska, Kasia, White, Nicholas J., Jaffar, Shabbar, Harrison, Thomas S.·2009·Clinical Infectious Diseases
DOI 10.1086/604716

Cited by (227)

Items 101–200 of 227

  1. Antifungal adjuvants: Preserving and extending the antifungal arsenal
    Arielle Butts, Glen E. Palmer, Phillip David Rogers · 2016 · Virulence
  2. Trehalose as quantitative biomarker for in vivo diagnosis and treatment follow-up in cryptococcomas
    Liesbeth Vanherp, Jennifer Poelmans, Akila Weerasekera, Amy Hillen, A. Croitor Sava, Tania Christine Sorrell, Katrien Lagrou, Greetje Vande Velde, Uwe Himmelreich · 2020 · Translational research
  3. Fungal Infections in Immunosuppressed Patients
    Luis Enrique Jerez Puebla · 2012 · InTech eBooks
  4. Management of Cryptococcal Meningitis in Sub-Saharan Africa
    Arthur Jackson, Mina C. Hosseinipour · 2010 · Current HIV/AIDS Reports
  5. Do Intracerebral Cytokine Responses Explain the Harmful Effects of Dexamethasone in Human Immunodeficiency Virus–associated Cryptococcal Meningitis?
    Justin Beardsley, Nhat Le Thanh Hoang, Freddie Kibengo, Nguyen Le Nhu Tung, Trần Quang Bình, Le Quoc Hung, Wirongrong Chierakul, Guy Edward Thwaites, Nguyễn Văn Vĩnh Châu, Thuong Thuong Nguyen et al. · 2018 · Clinical Infectious Diseases
  6. High-Throughput Screen in Cryptococcus neoformans Identifies a Novel Molecular Scaffold That Inhibits Cell Wall Integrity Pathway Signaling
    Hartland, Kate, Pu, Jun, Palmer, Michelle, Dandapani, Sivaraman, Moquist, Philip N., Munoz, Benito, DiDone, Louis, Schreiber, Stuart L., Krysan, Damian J. · 2016 · ACS Infectious Diseases
  7. AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial
    Mooketsi Molefi, Awilly A Chofle, Síle F. Molloy, Samuel Elias Kalluvya, John M. Changalucha, Francesca Cainelli, Tshepo Leeme, Nametso Lekwape, Drew W. Goldberg, Miriam R. Haverkamp et al. · 2015 · Trials
  8. Immune Modulators as Adjuncts for the Prevention and Treatment of Invasive Fungal Infections
    Regina Pikman, Ronen Ben‐Ami · 2012 · Immunotherapy
  9. New Insights in the Prevention, Diagnosis, and Treatment of Cryptococcal Meningitis
    Arthur Jackson, Charles van der Horst · 2012 · Current HIV/AIDS Reports
  10. Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma
    Thomas S. Uldrick, Sharon S. Pipkin, Susan Scheer, Nancy A. Hessol · 2013 · AIDS
  11. Fungal Infections of the Central Nervous System
    Dan Tong Jia, Kiran Teresa Thakur · 2019 · Seminars in Neurology
  12. Early Fungicidal Activity as a Candidate Surrogate Endpoint for All-Cause Mortality in Cryptococcal Meningitis: A Systematic Review of the Evidence
    Jairo Mauricio Montezuma-Rusca, John H. Powers, Dean A. Follmann, Jing Wang, Brigit Sullivan, Peter Richard Williamson · 2016 · PLoS ONE
  13. Antifungal drug screening: thinking outside the box to identify novel antifungal scaffolds
    Sarah R. Beattie, Damian J. Krysan · 2020 · Current Opinion in Microbiology
  14. Continuous Infusion of Amphotericin B Deoxycholate in the Treatment of Cryptococcal Meningoencephalitis: Analysis of Safety and Fungicidal Activity
    Diego R. Falci, Luciano Weber Lunardi, Carina Ramos, Mônica Baumgardt Bay, Valério Rodrigues Aquino, Luciano Zubaran Goldani · 2010 · Clinical Infectious Diseases
  15. Variability of Phenotypic Traits in Cryptococcus Varieties and Species and the Resulting Implications for Pathogenesis
    Gunjan Gupta, Bettina C. Fries · 2010 · Future Microbiology
  16. Rapid Microscopy and Use of Vital Dyes: Potential to Determine Viability of Cryptococcus neoformans in the Clinical Laboratory
    Brendan Joseph McMullan, Desmarini Desmarini, Julianne T. Djordjevic, Wen Chen, Michael P. V. Roper, Tania Christine Sorrell · 2015 · PLoS ONE
  17. Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis
    Fátima Concha-Velasco, Elsa González-Lagos, Carlos Seas, Beatriz Bustamante · 2017 · PLoS ONE
  18. Efficacy of ventriculoperitoneal shunting in patients with cryptococcal meningitis with intracranial hypertension
    Ying Liu, Xiaohua Peng, Weizhen Weng, Jianyun Zhu, Hong Cao, Shi-Bin Xie · 2019 · International Journal of Infectious Diseases
  19. Prognosis and management of cryptococcal meningitis in patients with human immunodeficiency virus infection
    David R. Boulware, Joshua Rhein · 2012 · Neurobehavioral HIV Medicine
  20. Predictors of outcome in routine care for Cryptococcal meningitis in Western Kenya: lessons for HIV outpatient care in resource-limited settings
    Caroline Kendi, Jeremy Penner, Julius Koech, Mary Akinyi Nyonda, Craig R. Cohen, Elizabeth Anne Bukusi, Evelyn W. Ngugi, Ana-Claire Meyer · 2012 · Postgraduate Medical Journal
  21. Cytokine patterns in a prospective cohort of HIV-infected patients with cryptococcal meningitis following initiation of antifungal and antiretroviral therapy
    Delio José Mora, Kennio Ferreira Paim, Leonardo Eurípedes Andrade-Silva, Thatiane Bragine, Ivonete Helena Rocha, Bárbara de Melo Ribeiro, Guilherme Henrique Machado, Virmondes Rodrigues, David Nascimento Silva-Teixeira, Wieland Meyer et al. · 2017 · PLoS ONE
  22. High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis
    Julliana Ribeiro Alves dos Santos, Noelly Queiroz Ribeiro, Rafael Wesley Bastos, Rodrigo Assunção Holanda, Letícia Chagas da Silva, ESTELA R. QUEIROZ, Daniel Assis Santos · 2017 · Scientific Reports
  23. Antifungal Clinical Trials and Guidelines: What We Know and Do Not Know
    Peter G. Pappas · 2014 · Cold Spring Harbor Perspectives in Medicine
  24. Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings
    Sarah M Lofgren, Mahsa Abassi, Joshua Rhein, David R. Boulware · 2017 · Expert Review of Anti-infective Therapy
  25. Prevalence of cryptococcal meningitis among people living with human immuno-deficiency virus and predictors of mortality in adults on induction therapy in Africa: A systematic review and meta-analysis
    Seke G. Y. Muzazu, Dawit Getachew Assefa, Christabel Chigwe Phiri, Tewodros Getinet, Samrawit Solomon, Gizachew Yismaw, Tsegahun Manyazewal · 2022 · Frontiers in Medicine
  26. Cryptococcal Meningitis: Current Approaches to Management in Patients With and Without AIDS
    Kyle D. Brizendine, Peter G. Pappas · 2010 · Current Infectious Disease Reports
  27. Epidemiological characterization and prognostic factors in patients with confirmed cerebral cryptococcosis in central Taiwan
    Chang‐Hua Chen, Hiu‐Ngar Sy, Li-Jhen Lin, Hua-Cheg Yen, SHAO‐HUNG WANG, Wei‐Liang Chen, Yu-Min Chen, Yu‐Jun Chang · 2015 · The Journal of venomous animals and toxins including tropical diseases
  28. Very Low Levels of 25-Hydroxyvitamin D Are Not Associated With Immunologic Changes or Clinical Outcome in South African Patients With HIV-Associated Cryptococcal Meningitis
    Joseph N Jarvis, Tihana A. Bicanic, Angela Loyse, Graeme Meintjes, Louise E. Hogan, Chrissy h. Roberts, Shmuel Shoham, John R. Perfect, Nelesh Premapragasan Govender, Thomas Stephen Harrison · 2014 · Clinical Infectious Diseases
  29. Micro- and Nanoscale Approaches in Antifungal Drug Discovery
    Ronnie Willaert · 2018 · Fermentation
  30. Genetic influence of Toll-like receptors on non-HIV cryptococcal meningitis: An observational cohort study
    Ying‐Kui Jiang, Jiqin Wu, Hua‐Zhen Zhao, Xuan Wang, Ruiying Wang, Ling‐Hong Zhou, Ching‐Wan Yip, Liping Huang, Jia-Hui Cheng, Yahong Chen et al. · 2018 · EBioMedicine
  31. Elevated Intracranial Pressure in Cryptococcal Meningoencephalitis: Examining Old, New, and Promising Drug Therapies
    Abdulaziz H. Alanazi, Mir S. Adil, Xiaorong Lin, Daniel B. Chastain, Andrés F. Henao‐Martínez, Carlos Franco‐Paredes, Payaningal R. Somanath · 2022 · Pathogens
  32. Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality
    Caleb P Skipper, Katherine Huppler Hullsiek, Anna Stadelman, Darlisha A Williams, Kenneth Ssebambulidde, Elizabeth C Okafor, Lillian Tugume, Edwin Nuwagira, Andrew Akampurira, Abdu K Musubire et al. · 2022 · Journal of Fungi
  33. How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus–Associated Cryptococcal Meningitis to High-Income Settings?
    Thomas Stephen Harrison, David Stephen Lawrence, Henry Charles Mwandumba, David R. Boulware, Mina C. Hosseinipour, Olivier Lortholary, Graeme Meintjes, Mosepele Mosepele, Joseph N Jarvis · 2022 · Clinical Infectious Diseases
  34. Cryptococcosis in the Developing World: An Elephant in the Parlor
    Peter G. Pappas · 2009 · Clinical Infectious Diseases
  35. Fluconazole plus flucytosine is a good alternative therapy for non‐ HIV and non‐transplant‐associated cryptococcal meningitis: A retrospective cohort study
    Zhanyi Li, Yu Liu, Yutian Chong, Xiangyong Li, Yusheng Jie, Xiaoyan Zheng, Ying Yan · 2019 · Mycoses
  36. Efficiently Killing a Sugar-Coated Yeast
    John R. Perfect · 2013 · New England Journal of Medicine
  37. Treatment Principles for Candida and Cryptococcus
    Laura Whitney, Tihana A. Bicanic · 2014 · Cold Spring Harbor Perspectives in Medicine
  38. Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome
    Timothée Boyer‐Chammard, Elvis Temfack, Olivier Lortholary, Alexandre Alanio · 2018 · Memórias do Instituto Oswaldo Cruz
  39. Radiolabeled Antibodies for Therapy of Infectious Diseases
    Ekaterina Dadachova, Arturo Casadevall · 2014 · Microbiology Spectrum
  40. Colliding Epidemics and the Rise of Cryptococcosis
    Christina C. Chang, Sharon Chia-Ju Chen · 2015 · Journal of Fungi
  41. Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease
    Kathryn Boyd, Vinie Kouamou, Admire Hlupeni, Zorodzai Tangwena, Chiratidzo Ellen Ndhlovu, Tariro Makadzange, CryptoART Study Team · 2022 · Microbiology Spectrum
  42. Efficacy of APX2039 in a Rabbit Model of Cryptococcal Meningitis
    Charles D. Giamberardino, Wiley A. Schell, Jennifer L. Tenor, Dena L. Toffaletti, Julia R. Palmucci, Choiselle Marius, Jane-Valeriane K. Boua, Quinlyn A. Soltow, Robert S. Mansbach, Martin Arthur Moseley et al. · 2022 · mBio
  43. Refractory and/or Relapsing Cryptococcosis Associated with Acquired Immune Deficiency Syndrome: Clinical Features, Genotype, and Virulence Factors of Cryptococcus spp. Isolates
    Érika Nascimento, Lúcia Helena Vitali, Ludmilla Tonani, Márcia Regina von Zeska Kress, Osvaldo Massaiti Takayanagui, Roberto Martínez · 2016 · American Journal of Tropical Medicine and Hygiene
  44. Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study
    Li Xu, Jia Liu, Qilong Zhang, Min Li, Jingchi Liao, Weifeng Kuang, Cansheng Zhu, Huan Yi, Fuhua Peng · 2018 · Neurological Research
  45. Comparative Effectiveness of Induction Therapy for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: A Network Meta-Analysis
    Jeffrey I. Campbell, Steve Kanters, John E. Bennett, Kristian Thorlund, Alexander C. Tsai, Edward J. Mills, Mark Jacob Siedner · 2015 · Open Forum Infectious Diseases
  46. Benzothiourea Derivatives Target the Secretory Pathway of the Human Fungal Pathogen Cryptococcus neoformans
    Beattie, Sarah R., Schnicker, Nicholas J., Murante, Thomas, Kettimuthu, Kavitha, Williams, Noelle S., Gakhar, Lokesh, Krysan, Damian J. · 2020 · ACS Infectious Diseases
  47. IL-6 deficiency accelerates cerebral cryptococcosis and alters glial cell responses
    Marta Reguera-Gómez, Melissa E. Munzen, Mohamed F. Hamed, Claudia Lisette Charles Niño, Luis R. Martinez · 2024 · Journal of Neuroinflammation
  48. Fluconazole Resistance and Virulence in In Vitro Induced-Fluconazole Resistant Strains and in Clinical Fluconazole Resistant Strain of Cryptococcus deuterogattii
    Sébastien Bertout, Laëtitia Laroche, Frédéric Roger, Donika Krasteva, Pascal Drakulovski, Virginie Bellet · 2023 · Pathogens
  49. Development and validation of a machine learning model to predict prognosis in HIV-negative cryptococcal meningitis patients: a multicenter study
    Junyu Liu, Yaxin Lu, Jia Liu, Jiayin Liang, Qilong Zhang, Hua Li, Xiufeng Zhong, Hui Bu, Zhanhang Wang, Liuxu Fan et al. · 2023 · European Journal of Clinical Microbiology & Infectious Diseases
  50. British HIV Association opportunistic infection guidelines: in defence of amphotericin B deoxycholate
    Tihana A. Bicanic, D Ogden, Laura Whitney, Angela Loyse, Joseph N Jarvis · 2012 · HIV Medicine
  51. Combination Therapy for HIV-Associated Cryptococcal Meningitis—A Success Story
    William James Hurt, Thomas Stephen Harrison, Síle F. Molloy, Tihana A. Bicanic · 2021 · Journal of Fungi
  52. Cryptococcosis
    Eileen K Maziarz, John R. Perfect · 2023 · Springer eBooks
  53. Clinical features and treatment outcomes of human immunodeficiency virus-associated cryptococcal meningitis: a 2-year retrospective analysis
    Wei Song, Yinzhong Shen, Zhenyan Wang, Tangkai Qi, Li Liu, Ren-Fang Zhang, Jiangrong Wang, Yang Tang, Jun Chen, Jianjun Sun et al. · 2020 · Chinese Medical Journal
  54. Combination Versus Monotherapy for the Treatment of HIV Associated Cryptococcal Meningitis
    Shashank Anant Vaidhya · 2015 · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
  55. Association between neuroimaging and clinical outcomes in individuals with central nervous system cryptococcosis
    Juliana Cavadas Teixeira, Vítor Falcão de Oliveira, Hélio Rodrigues Gomes, Suzana Mesquita Ribeiro, Evangelina da Motta Pacheco Alves de Araújo, Isabela Carvalho Leme Vieira da Cruz, Mariane Taborda, Adriana Satie Gonçalves Kono Magri, José Ernesto Vidal, Ana Catharina de Seixas Santos Nastri et al. · 2024 · Mycoses
  56. Epidemiological, clinical and biological profile of neuromeningeal cryptococcosis among people living with in Kinshasa, Democratic Republic of Congo
    Bive Zono, Erick Ntambwe Kamangu, Hippolyte Nani-Tuma Situakibanza, Evelyne Amaela, Ben Izizag Bepouka, Marcel Mbula, Jean-Marie Kayembe, Georges Lelo Mvumbi, Marie‐Pierre Hayette · 2020 · Pan African Medical Journal
  57. Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis
    Charles D. Giamberardino, Jennifer L. Tenor, Dena L. Toffaletti, Julia R. Palmucci, Wiley A. Schell, Jane-Valeriane K. Boua, Choiselle Marius, Katharine Elizabeth Stott, Shelby L. Steele, William W. Hope et al. · 2023 · Antimicrobial Agents and Chemotherapy
  58. Cryptococcus neoformansas a Model for Radioimmunotherapy of Infections
    Ekaterina Dadachova, Arturo Casadevall · 2011 · Interdisciplinary Perspectives on Infectious Diseases
  59. Efficacy of intrathecal liposomal amphotericin B plus oral posaconazole in the treatment of acute meningeal cryptococcosis in a murine model
    Javier Capilla, Alexandra Flavia, Emilio Mayayo, Josep Guarro · 2013 · International Journal of Antimicrobial Agents
  60. Reimagining the future of African brain health: Perspectives for basic research on the pathogenesis of cryptococcal meningitis
    Rachael Dangarembizi · 2021 · Brain Behavior & Immunity - Health
  61. Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitis
    Katharine Elizabeth Stott, Jason T. Mohabir, Katharine Bowers, Jennifer L. Tenor, Dena L. Toffaletti, Jennifer Unsworth, Ana Jimenez‐Valverde, Ajisa Ahmadu, Melanie Moyo, Ebbie Gondwe et al. · 2024 · mBio
  62. Efficacy of induction regimens for cryptococcal meningitis in HIV-infected adults: a systematic review and network meta-analysis
    Chang‐Hua Chen, Hua Li, Hsien-Meng Chen, Yu-Min Chen, Yu‐Jun Chang, Pao‐Yen Lin, Chih‐Wei Hsu, Ping‐Tao Tseng, Kai-Huang Lin, Yu‐Kang Tu · 2021 · Scientific Reports
  63. Cryptococcosis in Africa
    Nelesh Premapragasan Govender, Thomas G. Mitchell, Anastasia P. Litvintseva, Kathleen J. Miglia · 2014 · ASM Press eBooks
  64. Warfare and defense: The host response to Cryptococcus infection
    Fabianno F. Dutra, Priscila Costa Albuquerque, Márcio Lourenço Rodrigues, Fernanda L. Fonseca · 2017 · Fungal Biology Reviews
  65. Management of Cryptococcal Meningoencephalitis in Both Developed and Developing Countries
    Joseph N Jarvis, Tihana A. Bicanic, Thomas Stephen Harrison · 2014 · ASM Press eBooks
  66. Transcriptional Profiling of Patient Isolates Identifies a Novel TOR/Starvation Regulatory Pathway in Cryptococcal Virulence
    Yoon‐Dong Park, Joseph N Jarvis, Guowu Hu, Sarah E. Davis, Jin Feng Qiu, Nannan Zhang, Christopher Hollingsworth, Angela Loyse, Paul J. Gardina, Tibor Vályi-Nagy et al. · 2018 · mBio
  67. Usefulness of Yeast Cell Counting and Lack of Clinical Correlation of the Antifungal Susceptibility Testing Results in Management of Aids-associated Cryptococcal Meningitis
    Oscar José Chagas, Renata Buccheri, Márcia de Souza Carvalho Melhem, Walderez Szeszs, Marilena dos Anjos Martins, Lidiane de Oliveira, Rosa Maria Nascimento Marcusso, Daniel Wagner de Castro Lima Santos · 2020 · Current Fungal Infection Reports
  68. The GATA-like transcription factor Gat201 determines alkaline-restricted growth in Cryptococcus neoformans
    E S Hughes, Laura Tuck, Zhenzhen He, Elizabeth Ripley Ballou, Edward W. J. Wallace · 2025 · mSphere
  69. Evaluating clinical outcome in non-HIV associated cryptococcal meningitis with negative CSF culture using microscopic quantitative cryptococcal counting
    Junyu Liu, Jia Liu, Lihui Xu, Lu Yang, Xiaohong Su, Yaxin Lu, Dongcheng Li, Zheqi Li, Chu Peng HOI, Ying Jiang et al. · 2025 · Diagnostic Microbiology and Infectious Disease
  70. Assessing Responses to Treatment of Opportunistic Mycoses and Salvage Strategies
    Baldeep Mona Wirk, John R. Wingard · 2011 · Current Infectious Disease Reports
  71. Cryptococcosis and other Fungal Infections (Histoplasmosis and Coccidioidomycosis) in HIV-infected Patients
    Kathleen Raquel Page, Richard E. Chaisson, Merle A. Sande · 2008 · Elsevier eBooks
  72. Radioimmunotherapy as a pathogen-agnostic treatment method for opportunistic mucormycosis infections
    Jorge Luis Costa CARVALHO, Mackenzie E. Malo, Kevin J H Allen, Connor Frank, Zhiwen Xiao, Rubin Jiao, Ekaterina Dadachova · 2023 · Access Microbiology
  73. What Can the Clinical Mycology Laboratory Do for Clinicians Today and Tomorrow?
    Ahmad Mourad, John R. Perfect · 2017 · Current Clinical Microbiology Reports
  74. Deceptively asymptomatic cryptococcaemia in a renal transplant recipient: the lull before a storm
    Vivek Sood, Navin Pattanashetti, Raja Ramachandran, Krishan Lal Gupta · 2019 · BMJ Case Reports
  75. Significance of immunotherapy for human fungal diseases and antifungal drug discovery
    Manzoor Ahmad Mir, Ulfat Jan, Hafsa Qadri · 2022 · Elsevier eBooks
  76. Obstetric Violence & Colonial Conditioning in South Africa's Reproductive Health System
    Jessica Rucell · 2017 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  77. IRIS and Fungal Infections: What Have We Learned?
    Eileen K Maziarz, John R. Perfect · 2011 · Current Fungal Infection Reports
  78. Cryptococcus neoformans: The Model Organism for Yeast Antifungal Drug Susceptibility Testing
    Madeline Bauer, Ann Thomas, Robert A. Larsen · 2012 · Mycopathologia
  79. Failure of Early Mycological Clearance in HIV-Negative Cryptococcal Meningitis
    Zhihui Su, Chongliang Luo, Kai Dai, Dasen Yuan, Bang‐e Qin, Meifeng Gu, Junyu Liu, Yong Chen, Fuhua Peng, Ying Jiang · 2023 · Open Forum Infectious Diseases
  80. Outcome Assessments in Clinical Trials of Cryptococcal Meningitis: Considerations on Use of Early Fungicidal Activity as a Potential Surrogate Endpoint for All-Cause Mortality
    Jairo Mauricio Montezuma-Rusca, John H. Powers · 2014 · Current treatment options in infectious diseases/Current treatment options in infectious disease
  81. Recent advances in management of cryptococcal meningitis: commentary
    Tania Christine Sorrell, Sharon C.‐A. Chen · 2010 · F1000 Medicine Reports
  82. Characteristics of Mortality in HIV-negative Cryptococcosis Patients: Analysis of a Cohort of 743 Patients
    Kai Dai, Xinyao Jian, Chongliang Luo, Siguang Wang, Qiyu Pan, Xiaofeng Xu, Jia Liu, Fuhua Peng, Yong Chen, Ying Jiang · 2026 · Open Forum Infectious Diseases
  83. Cryptococcosis
    Eileen K Maziarz, John R. Perfect · 2015 · Springer eBooks
  84. Therapy of AIDS-Related Cryptococcal Meningitis
    Neil R. H. Stone, Tihana A. Bicanic · 2014 · Current treatment options in infectious diseases/Current treatment options in infectious disease
  85. Advancing Translational Immunology in HIV-Associated Cryptococcal Meningitis
    Peter Richard Williamson · 2013 · The Journal of Infectious Diseases
  86. A review of the management and outcome of patients admitted with cryptococcal meningitis at a regional hospital in KwaZulu-Natal province
    Andrew John Ross, Egide Ndayishimiye · 2019 · South African Family Practice
  87. Cryptococcal meningitis in patients with and without acquired immunodeficiency
    Yumi de Oliveira Ohnishi, Antonio Saulo Leão Pantoja, Luciano Sami de Oliveira Abraão, Natália Guedes Alves, Maria Deise de Oliveira Ohnishi, Rosana Maria Feio Libonati, Ana Maria Revorêdo da Silva Ventura, Vera Regina da Cunha Menezes Palácios · 2021 · Acta Tropica
  88. Radiolabeled Antibodies for Therapy of Infectious Diseases
    Ekaterina Dadachova, Arturo Casadevall · 2015 · ASM Press eBooks
  89. Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial
    Morris K Rutakingirwa, Caleb P Skipper, Biyue Dai, Abduljewad Wele, Suzan Namombwe, Timothy Mugabi, Jane Francis Ndyetukira, Alisat Sadiq, Mable Kabahubya, Lenard Chemusto et al. · 2025 · Clinical Infectious Diseases
  90. A Study of Clearance of Infection in HIV-Associated Cryptococcal Meningitis after Amphotericin-Based Induction and Fluconazole-Based Consolidation Therapy
    Sorokhaibam Bhagyabati Devi, Raghavendra Ashok Navi, Thangjam Suraj, Ningthoukhongjam Reema, Thangjam Gautam Singh, Medo M. Kuotsu, Nyamnyei Konyak · 2021 · International Journal of Recent Surgical and Medical Sciences
  91. Fungal infections
    Roderick J. Hay · 2013 · Cambridge University Press eBooks
  92. Cryptococcal Meningitis
    Ahmed Al Hammadi, Luis L. Ostrosky-Zeichner · 2018 · Springer eBooks
  93. Companion Drugs for Amphotericin B in Cryptococcal Meningitis: Flucytosine, Fluconazole, or…Nothing?
    John E. Bennett · 2011 · Clinical Infectious Diseases
  94. Development and Validation of a Machine Learning Model to Predict Prognosis in HIV-Negative Cryptococcal Meningitis Patients: A Multicentre Retrospective Study
    Junyu Liu, Yaxin Lu, Jia Liu, Jiayin Liang, Qilong Zhang, Hua Li, Xiufeng Zhong, Hui Bu, Zhanhang Wang, Liuxu Fan et al. · 2022 · Research Square
  95. A trade-off between proliferation and defense in the fungal pathogen Cryptococcus at alkaline pH is controlled by the transcription factor GAT201
    Elizabeth S. Hughes, Laura Tuck, Zhenzhen He, Elizabeth Ripley Ballou, Edward W. J. Wallace · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Change in Global Incidence and Mortality of Invasive Fungal Infection
    Masoud Mardani · 2024 · Archives of Clinical Infectious Diseases
  97. An Overview on Cryptococcal Meningitis
    Márcia de Souza Carvalho Melhem, Mara C.S.M. Pappalardo · 2012 · InTech eBooks
  98. Future strategies for the treatment of cryptococcal meningoencephalitis in pediatric patients
    Justin R. Spivey, Richard H. Drew, John R. Perfect · 2014 · Expert Opinion on Orphan Drugs
  99. Seroprevalence of cryptoccocal antigenemia in HIV positive adult inpatients with severe immunosuppresion attending the Kenyatta National and Mbagathi Hospitals
    Irene W Muchiri · 2013
  100. Yeast Biotechnology 2.0
    Ronnie Willaert · 2018 · MDPI eBooks